SOURCE: Medistem Laboratories

October 31, 2007 08:05 ET

Medistem Laboratories to Present at the Rodman & Renshaw 9th Annual Healthcare Conference

SCOTTSDALE, AZ--(Marketwire - October 31, 2007) - Medistem Laboratories (OTCBB: MDSM) announced today that Thomas Ichim, Chief of Scientific Development, will present a company update at the 9th Annual Acumen BioFin Rodman & Renshaw conference in New York on Monday, November 5, 2007 at 10:55 a.m. eastern time (ET). Ichim's talk will address recent results from Medistem's basic research and pre-clinical activities surrounding the Tolerostem and Angiostem platforms; along with other company developments.

The presentation will also be available via webcast. Interested parties can access the webcast at

About Medistem Laboratories, Inc.

Medistem Laboratories is a biotechnology company that discovers, develops, and commercializes adult stem cell products that address serious medical conditions. While drug discovery and development is its primary focus, Medistem has compiled a body of proprietary technologies it outlicenses to commercial entities in markets where stem cell administration is permissible. Due to its licensee relationships and collaborative efforts with respected institutions, Medistem believes it is well positioned to be a leading developer of adult stem cell products.

Contact Information